Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation

Clin Lung Cancer. 2018 Jan;19(1):e57-e61. doi: 10.1016/j.cllc.2017.07.003. Epub 2017 Aug 3.
No abstract available

Keywords: Crizotinib; DIC; Intensive care; NSCLC; ROS1.

MeSH terms

  • Adult
  • Carcinoma, Non-Small-Cell Lung / diagnosis*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Crizotinib / therapeutic use*
  • Disseminated Intravascular Coagulation
  • Dyspnea
  • Female
  • Gene Rearrangement
  • Hemoptysis
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / genetics
  • Neoplasm Metastasis
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / genetics*
  • Protein-Tyrosine Kinases / metabolism
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins / metabolism
  • Remission Induction
  • Respiratory Distress Syndrome

Substances

  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Crizotinib
  • Protein-Tyrosine Kinases
  • ROS1 protein, human